Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Vivani Medical, Inc.VANI · Entity 6636 | Director · Chief Executive Officer | July 28, 2026 | July 31, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Vivani Medical, Inc.
Report date July 28, 2026 · Filed July 31, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common Stock OptionSEC Table II · derivative / convertible security · Conversion / exercise price $1.31 · Expires 2036-07-27 | Direct | 200,000 |
Reported balance
After 2026-07-28 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2026-07-28 · Grant · Acquired 200,000 · Balance 200,000 F1: The stock options have a 10-year term and vest 25% at one-year and monthly thereafter for 36 months, subject to the Reporting Person's continued service through each applicable vesting date. |
| RSUsSEC Table II · derivative / convertible security | Direct | 100,000 |
Reported balance
After 2026-07-28 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2026-07-28 · Grant · Acquired 100,000 · Balance 100,000 F2: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Vivani common stock. F3: The performance based RSUs shall vest in three stages: one-third when the stock price is at or above $3.15 for three consecutive trading days, another one-third one year after this date when the market condition is first achieved, and the final one-third one year after this second vesting date when the market condition is achieved, subject to the Reporting Person's continued service through each applicable vesting date. If the RSUs fail to be at or above $3.15 for three consecutive trading dates within a four year term from the date of the grant, the RSUs shall expire. |
Filing footnotes · ownership attribution and instrument terms
F1: The stock options have a 10-year term and vest 25% at one-year and monthly thereafter for 36 months, subject to the Reporting Person's continued service through each applicable vesting date.
F2: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Vivani common stock.
F3: The performance based RSUs shall vest in three stages: one-third when the stock price is at or above $3.15 for three consecutive trading days, another one-third one year after this date when the market condition is first achieved, and the final one-third one year after this second vesting date when the market condition is achieved, subject to the Reporting Person's continued service through each applicable vesting date. If the RSUs fail to be at or above $3.15 for three consecutive trading dates within a four year term from the date of the grant, the RSUs shall expire.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| July 28, 2026 Filed Jul 31, 2026 00:24 UTC | Vivani Medical, Inc. VANI · Entity 6636 | GrantRSUs · Derivative | 100,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001753926-26-001282 · form4.xml · derivative · entry 2 Mendelsohn Adam · CIK 0001940008 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 100,000 Underlying: Common Stock · 100,000 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Vivani common stock. F3 · derivative.exercise_date: The performance based RSUs shall vest in three stages: one-third when the stock price is at or above $3.15 for three consecutive trading days, another one-third one year after this date when the market condition is first achieved, and the final one-third one year after this second vesting date when the market condition is achieved, subject to the Reporting Person's continued service through each applicable vesting date. If the RSUs fail to be at or above $3.15 for three consecutive trading dates within a four year term from the date of the grant, the RSUs shall expire. F3 · derivative.expiration_date: The performance based RSUs shall vest in three stages: one-third when the stock price is at or above $3.15 for three consecutive trading days, another one-third one year after this date when the market condition is first achieved, and the final one-third one year after this second vesting date when the market condition is achieved, subject to the Reporting Person's continued service through each applicable vesting date. If the RSUs fail to be at or above $3.15 for three consecutive trading dates within a four year term from the date of the grant, the RSUs shall expire. Read SEC document |
| July 28, 2026 Filed Jul 31, 2026 00:24 UTC | Vivani Medical, Inc. VANI · Entity 6636 | GrantCommon Stock Option · Derivative | 200,000 | $0.00 Strike: $1.31 | $0.00 |
DisclosureSEC source: 0001753926-26-001282 · form4.xml · derivative · entry 1 Mendelsohn Adam · CIK 0001940008 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 200,000 Underlying: Common Stock · 200,000 shares Expires 2036-07-27 F1 · derivative.exercise_date: The stock options have a 10-year term and vest 25% at one-year and monthly thereafter for 36 months, subject to the Reporting Person's continued service through each applicable vesting date. F1 · derivative.expiration_date: The stock options have a 10-year term and vest 25% at one-year and monthly thereafter for 36 months, subject to the Reporting Person's continued service through each applicable vesting date. Read SEC document |
| May 12, 2025 Filed May 15, 2025 00:18 UTC | Vivani Medical, Inc. VANI · Entity 6636 | GrantRSUs · Derivative | 100,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001753926-25-000822 · form4.xml · derivative · entry 2 Mendelsohn Adam · CIK 0001940008 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 100,000 Underlying: Common Stock · 100,000 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Vivani common stock. F3 · derivative.exercise_date: The performance based RSUs shall vest in three stages: one-third when the stock price closes at or above $3.15 for three consecutive days, another one-third one year after this date when the market condition is first achieved, and the final one-third one year after this second vesting date when the market condition is achieved, subject to the Reporting Person's continued service through each applicable vesting date. If the RSUs fail to close at or above $3.15 for three consecutive trading dates within a four year term from the date of the grant, the RSUs shall expire. F3 · derivative.expiration_date: The performance based RSUs shall vest in three stages: one-third when the stock price closes at or above $3.15 for three consecutive days, another one-third one year after this date when the market condition is first achieved, and the final one-third one year after this second vesting date when the market condition is achieved, subject to the Reporting Person's continued service through each applicable vesting date. If the RSUs fail to close at or above $3.15 for three consecutive trading dates within a four year term from the date of the grant, the RSUs shall expire. Read SEC document |
| May 12, 2025 Filed May 15, 2025 00:18 UTC | Vivani Medical, Inc. VANI · Entity 6636 | GrantCommon Stock Option · Derivative | 200,000 | $0.00 Strike: $1.03 | $0.00 |
DisclosureSEC source: 0001753926-25-000822 · form4.xml · derivative · entry 1 Mendelsohn Adam · CIK 0001940008 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 200,000 Underlying: Common Stock · 200,000 shares Expires 2035-05-11 F1 · derivative.exercise_date: The stock options have a 10-year term and vest 25% at one-year and monthly thereafter for 36 months, subject to the Reporting Person's continued service through each applicable vesting date. F1 · derivative.expiration_date: The stock options have a 10-year term and vest 25% at one-year and monthly thereafter for 36 months, subject to the Reporting Person's continued service through each applicable vesting date. Read SEC document |
| May 10, 2024 Filed May 14, 2024 22:52 UTC | Vivani Medical, Inc. VANI · Entity 6636 | GrantRestricted Stock Units · Derivative | 100,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001753926-24-000966 · ownership.xml · derivative · entry 2 Mendelsohn Adam · CIK 0001940008 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 100,000 Underlying: Common Stock · 100,000 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Vivani common stock. F3 · derivative.exercise_date: The performance based RSUs shall vest in three stages: one-third when the stock price is at or above $3.15 for three consecutive trading days, another one-third one year after this date when the market condition is first achieved, and the final one-third one year after this second vesting date when the market condition is achieved, subject to the Reporting Person's continued service through each applicable vesting date. If the RSUs fail to be at or above $3.15 for three consecutive trading dates within a four year term from the date of the grant, the RSUs shall expire. F3 · derivative.expiration_date: The performance based RSUs shall vest in three stages: one-third when the stock price is at or above $3.15 for three consecutive trading days, another one-third one year after this date when the market condition is first achieved, and the final one-third one year after this second vesting date when the market condition is achieved, subject to the Reporting Person's continued service through each applicable vesting date. If the RSUs fail to be at or above $3.15 for three consecutive trading dates within a four year term from the date of the grant, the RSUs shall expire. Read SEC document |
| May 10, 2024 Filed May 14, 2024 22:52 UTC | Vivani Medical, Inc. VANI · Entity 6636 | GrantCommon Stock Option · Derivative | 200,000 | $0.00 Strike: $1.81 | $0.00 |
DisclosureSEC source: 0001753926-24-000966 · ownership.xml · derivative · entry 1 Mendelsohn Adam · CIK 0001940008 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 200,000 Underlying: Common Stock · 200,000 shares Expires 2034-05-09 F1 · derivative.exercise_date: The stock options have a 10-year term and vest 25% at one-year and monthly thereafter for 36 months, subject to the Reporting Person's continued service through each applicable vesting date. F1 · derivative.expiration_date: The stock options have a 10-year term and vest 25% at one-year and monthly thereafter for 36 months, subject to the Reporting Person's continued service through each applicable vesting date. Read SEC document |
| March 06, 2023 Filed Mar 9, 2023 02:32 UTC | Vivani Medical, Inc. VANI · Entity 6636 | GrantRSU · Derivative | 100,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001753926-23-000259 · ownership.xml · derivative · entry 2 Mendelsohn Adam · CIK 0001940008 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,000 Underlying: Common Stock · 100,000 shares Expires 2027-03-06 F1 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of Vivani common stock. F3 · shares: First third of RSUs vest when the stock price is at or above $3.15 for three consecutive business days. Second third vests one year after that. Final third vests one year after the second third. If the RSUs fail to reach $3.15 for three consecutive business days within a four year term from the date of the grant the RSUs expire. Read SEC document |
| March 06, 2023 Filed Mar 9, 2023 02:32 UTC | Vivani Medical, Inc. VANI · Entity 6636 | GrantCommon Stock Option · Derivative | 200,000 | $0.00 Strike: $1.09 | $0.00 |
DisclosureSEC source: 0001753926-23-000259 · ownership.xml · derivative · entry 1 Mendelsohn Adam · CIK 0001940008 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 200,000 Underlying: Common Stock · 200,000 shares Expires 2033-03-06 F2 · shares: The stock options have a 10-year term and vest immediately when share price closes at $6.30 for three consecutive business days. If the options fail to reach $6.30 for three consecutive business days within a four year term from the date of grant the options expire. Read SEC document |
| February 08, 2023 Filed Feb 10, 2023 23:42 UTC | Vivani Medical, Inc. VANI · Entity 6636 | GiftCommon Stock | 17,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001753926-23-000124 · ownership.xml · nonDerivative · entry 1 Mendelsohn Adam · CIK 0001940008 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,605,015 F1 · kind: Represents shares of common stock gifted to a non-family member. Read SEC document |
| January 19, 2023 Filed Jan 24, 2023 02:13 UTC | Vivani Medical, Inc. VANI · Entity 6636 | GrantCommon Stock Option · Derivative | 200,000 | $0.00 Strike: $1.27 | $0.00 |
DisclosureSEC source: 0001753926-23-000082 · ownership.xml · derivative · entry 1 Mendelsohn Adam · CIK 0001940008 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 200,000 Underlying: Common Stock · 200,000 shares Expires 2033-01-19 F1 · shares: The stock options have a 10-year term and vest 25% at one-year and monthly for 36 months thereafter on an equal basis. Read SEC document |
| August 30, 2022 Filed Aug 31, 2022 22:43 UTC | Vivani Medical, Inc. VANI · Entity 6636 | OtherWarrant · Derivative | 4,585 | $0.00 Strike: $3.15 | $0.00 |
DisclosureSEC source: 0001753926-22-001196 · ownership.xml · derivative · entry 5 Mendelsohn Adam · CIK 0001940008 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,585 Underlying: Common Stock · 4,585 shares Expires 2023-12-14 F5 · kind: Represents warrants to purchase shares of common stock assumed on the effective date of the acquisition of Nano Precision Medical, Inc., consummated on August 30, 2022 pursuant to the Agreement and Plan of Merger dated February 4, 2022. Read SEC document |
| August 30, 2022 Filed Aug 31, 2022 22:43 UTC | Vivani Medical, Inc. VANI · Entity 6636 | OtherWarrant · Derivative | 31,774 | $0.00 Strike: $3.15 | $0.00 |
DisclosureSEC source: 0001753926-22-001196 · ownership.xml · derivative · entry 4 Mendelsohn Adam · CIK 0001940008 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,774 Underlying: Common Stock · 31,774 shares Expires 2023-11-26 F5 · kind: Represents warrants to purchase shares of common stock assumed on the effective date of the acquisition of Nano Precision Medical, Inc., consummated on August 30, 2022 pursuant to the Agreement and Plan of Merger dated February 4, 2022. Read SEC document |
| August 30, 2022 Filed Aug 31, 2022 22:43 UTC | Vivani Medical, Inc. VANI · Entity 6636 | OtherCommon Stock Option · Derivative | 60,373 | $0.00 Strike: $3.15 | $0.00 |
DisclosureSEC source: 0001753926-22-001196 · ownership.xml · derivative · entry 3 Mendelsohn Adam · CIK 0001940008 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,373 Underlying: Common Stock · 60,373 shares Expires 2028-11-13 F3 · kind: Represents the replacement option to be issued by Vivani Medical, Inc. (f/k/a Second Sight Medical Products, Inc.) at the effective time of the merger acquisition thereof, pursuant to the terms of the Agreement and Plan of Merger entered into on February 4, 2022. F4 · shares: The option vests 1/48 per month over the four years after the date of grant commencing on December 12, 2018, and the balance thereafter vests in full on the fifth anniversary of the date of grant. F4 · balance_after: The option vests 1/48 per month over the four years after the date of grant commencing on December 12, 2018, and the balance thereafter vests in full on the fifth anniversary of the date of grant. Read SEC document |
| August 30, 2022 Filed Aug 31, 2022 22:43 UTC | Vivani Medical, Inc. VANI · Entity 6636 | OtherCommon Stock | 90,558 | $0.00 | $0.00 |
DisclosureSEC source: 0001753926-22-001196 · ownership.xml · nonDerivative · entry 2 Mendelsohn Adam · CIK 0001940008 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Indirect · Trusts Disclosed balance after: 90,558 F1 · kind: Represents shares of common stock issued in the acquisition transaction of Nano Precision Medical Inc. consummated August 30, 2022. F2 · ownership.nature: Represents shares of common stock held by three trusts for the benefit of the children of the Reporting Person, over which the Reporting Person and his spouse have joint voting and diapositive authority. The Reporting Person disclaims pecuniary ownership in the shares of common stock held by the three trusts. Excludes 77,331 shares of common stock held by MFE, LLC in which the Reporting Person has a 10% ownership interest and therefore a pecuniary interest in such shares, but over which the Reporting Person does not have any voting or diapositive authority. Read SEC document |
| August 30, 2022 Filed Aug 31, 2022 22:43 UTC | Vivani Medical, Inc. VANI · Entity 6636 | OtherCommon Stock | 3,622,015 | $0.00 | $0.00 |
DisclosureSEC source: 0001753926-22-001196 · ownership.xml · nonDerivative · entry 1 Mendelsohn Adam · CIK 0001940008 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,622,015 F1 · kind: Represents shares of common stock issued in the acquisition transaction of Nano Precision Medical Inc. consummated August 30, 2022. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.